As the Pharmaceutical Manufacturers Group of the Manufacturers Association of Nigeria (PMG-MAN) is preparing for its biennial forum this year, it is working towards providing sustainable solutions to healthcare problems in Nigeria. Taking note of the poor Nigerian health indices such as life expectancy at birth, maternal mortality ratio, and infant mortality rate which are still relatively poor, the group (PMG-MAN), as a major stakeholder, has decided to adopt a broad based, robust and comprehensive approach for its Biennial Forum this year.
For more than thirty years, PMG-MAN has promoted Good Manufacturing Practice (GMP) by undertaking comprehensive and rigorous self–regulation. It has also contributed to government policy formulation and implementation, supported public sector activities, and engaged in CSR activities that have significantly improved other socio-economic aspects of life in Nigeria.
The PMG-MAN forum this year marks the commencement of its new engagement strategy, which will enable the development of an innovative approach to rigorously and comprehensively engage with the challenges in the pharmaceutical sector, as well as the industrial policy space in Nigeria.
The theme for the forum is “Medicines’ Security and National Self-Sufficiency: Maximising Medicines’ Manufacturing Capacity in Nigeria” and it has been carefully developed to align with Government’s apt policy thrust which emphasizes the contextual development of Nigerian solutions for Nigerian problems.
The Keynote Address this year will be delivered by Mr. Okey Akpa, the PMG-MAN Chairman, while Dr Mark Abani, who is the Non-Executive Director of Crown Agents and Lead Consultant of MSCA Projects, will follow on as Guest Speaker. Participants of the forum will mirror the multi-stakeholder approach being adopted by the group.
This year’s forum will hold on the 2nd June at the Abuja Transcorp. Policy Experts and Health Strategists have suggested that the forum as well as the development of the networks, structures and processes that follow it, will mark a fresh and innovative model in how medicines are provided for Nigerians.